L850-0120 Screening compound: N-[(2-chlorophenyl)methyl]-2-({4-ethyl-5-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-4H-1,2,4-triazol-3-yl}sulfanyl)acetamide

L850-0120 Screening compound: N-[(2-chlorophenyl)methyl]-2-({4-ethyl-5-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-4H-1,2,4-triazol-3-yl}sulfanyl)acetamide
L850-0120 Screening compound: N-[(2-chlorophenyl)methyl]-2-({4-ethyl-5-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-4H-1,2,4-triazol-3-yl}sulfanyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L850-0120
N-[(2-chlorophenyl)methyl]-2-({4-ethyl-5-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-4H-1,2,4-triazol-3-yl}sulfanyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L850-0120

Molecular Formula

C22H21ClN6O3S (C22 H21 ClN6 O3 S)

Compound Name

N-[(2-chlorophenyl)methyl]-2-({4-ethyl-5-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]-4H-1,2,4-triazol-3-yl}sulfanyl)acetamide

IUPAC name

N-[(2-chlorophenyl)methyl]-2-({4-ethyl-5-[3-(4-methoxyphenyl)-124-oxadiazol-5-yl]-4H-124-triazol-3-yl}sulfanyl)acetamide

SMILES

CCn1c(SCC(NCc(cccc2)c2Cl)=O)nnc1-c1nc(-c(cc2)ccc2OC)no1

InChI

InChI=1S/C22H21ClN6O3S/c1-3-29-20(21-25-19(28-32-21)14-8-10-16(31-2)11-9-14)26-27-22(29)33-13-18(30)24-12-15-6-4-5-7-17(15)23/h4-11H,3,12-13H2,1-2H3,(H,24,30)

InChI Key

YCYNIAQHNIWSKO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27479897

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

484.97

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.549

Distribution Coefficient, logD

4.549

Water Solubility, LogSw

-4.58

Polar Surface Area

87.658

Acid Dissociation Constant (pKa)

13.29

Base Dissociation Constant (pKb)

2.21

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

22.70

L850-0120 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Antibacterial Compounds Library (13827 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Infections
  • Immune system
  • animal
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L850-0120 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L850-0120?
Check Price and Availability of L850-0120, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L850-0120 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L850-0120
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L850-0120
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L850-0120 available by request